Skip to content

Clinical trials

Observational Neurofibromatoses trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurofibromatoses Phase: Observational Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20081
20091
20101
20111
20123
20151
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)2
National Institute of Neurological Disorders and Stroke (NINDS)2
John Jay High School1
Johns Hopkins University1
M.D. Anderson Cancer Center1
Massachusetts General Hospital1
Memorial Sloan Kettering Cancer Center1
National Institute of Mental Health (NIMH)1
Shriners Hospitals for Children1
The Children's Tumor Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurofibromatoses13
Neurofibromatosis 16
Neoplasms2
Neurofibroma2
Neurofibromatosis 22
Neuroma, Acoustic2
Anemia, Sickle Cell1
Ependymoma1
Glioma1
HIV Infections1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.